Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 2, p. 342, doi. 10.1093/cid/ciac769
- By:
- Publication type:
- Article
Works by Dimartino, Dacia
Results: 6
1
2
Generation of quality-controlled SARS-CoV-2 variant stocks.
- Published in:
- Nature Protocols, 2023, v. 18, n. 12, p. 3821, doi. 10.1038/s41596-023-00897-6
- By:
- Publication type:
- Article
3
Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City–from Alpha to Omicron.
- Published in:
- PLoS Pathogens, 2023, v. 18, n. 4, p. 1, doi. 10.1371/journal.ppat.1011348
- By:
- Publication type:
- Article
4
Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York.
- Published in:
- Virus Evolution, 2024, v. 10, n. 1, p. 1, doi. 10.1093/ve/veae035
- By:
- Publication type:
- Article
5
Amplification Artifact in SARS-CoV-2 Omicron Sequences Carrying P681R Mutation, New York, USA.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 4, p. 881, doi. 10.3201/eid2804.220146
- By:
- Publication type:
- Article
6
SMaRT lncRNA controls translation of a G‐quadruplex‐containing mRNA antagonizing the DHX36 helicase.
- Published in:
- EMBO Reports, 2020, v. 21, n. 6, p. 1, doi. 10.15252/embr.201949942
- By:
- Publication type:
- Article